Header cover image

German (DAX) Healthcare Sector Analysis

UpdatedJan 31, 2023
DataAggregated Company Financials
Companies61
  • 7D0.3%
  • 3M11.2%
  • 1Y-11.0%
  • YTD9.7%

The Healthcare industry has been flat over the last week, but Fresenius SE KGaA has lost 4.7%. As for the longer term, the industry has declined 11% in the last year. Looking forward, earnings are forecast to grow by 11% annually.

Sector Valuation and Performance

Has the German Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 31 Jan 2023€288.1b€187.6b€13.9b18.2x20.8x1.5x
Thu, 29 Dec 2022€262.9b€187.5b€13.9b21.3x18.9x1.4x
Sat, 26 Nov 2022€277.6b€187.4b€13.9b21.4x20x1.5x
Mon, 24 Oct 2022€246.8b€182.4b€13.4b20x18.4x1.4x
Wed, 21 Sep 2022€231.1b€178.6b€12.9b18.7x17.9x1.3x
Fri, 19 Aug 2022€284.7b€182.3b€13.4b18.3x21.2x1.6x
Sun, 17 Jul 2022€281.7b€178.5b€11.3b23.8x24.9x1.6x
Tue, 14 Jun 2022€287.2b€185.9b€11.4b23.2x25.2x1.5x
Thu, 12 May 2022€287.0b€184.9b€11.3b21.3x25.3x1.6x
Sat, 09 Apr 2022€321.1b€179.8b€10.0b25.3x32x1.8x
Mon, 07 Mar 2022€288.8b€178.3b€9.6b21.5x29.9x1.6x
Wed, 02 Feb 2022€325.6b€175.4b€9.3b26.2x35.2x1.9x
Fri, 31 Dec 2021€353.1b€175.4b€9.3b29.8x38.1x2x
Sun, 28 Nov 2021€343.8b€158.6b€9.3b28.7x37.1x2.2x
Tue, 26 Oct 2021€341.7b€154.6b€1.3b28.7x264.3x2.2x
Thu, 23 Sep 2021€343.8b€171.3b€1.3b30x271x2x
Sat, 21 Aug 2021€349.6b€171.3b€1.3b32.4x279.4x2x
Sat, 05 Jun 2021€292.1b€166.5b-€7,033,910,088.3330.6x-41.5x1.8x
Tue, 09 Mar 2021€268.1b€163.2b-€8,349,583,322.5629.4x-32.1x1.6x
Mon, 30 Nov 2020€257.6b€162.9b-€12,118,968,705.7134.6x-21.3x1.6x
Thu, 03 Sep 2020€248.0b€163.5b-€4,039,550,284.6132.8x-61.4x1.5x
Sun, 07 Jun 2020€257.9b€163.6b€6.0b33.1x42.7x1.6x
Sat, 29 Feb 2020€242.2b€159.9b€8.5b34.6x28.4x1.5x
Price to Earnings Ratio

30.6x


Total Market Cap: €263.7bTotal Earnings: €8.6bTotal Revenue: €159.9bTotal Market Cap vs Earnings and Revenue0%0%0%
German Healthcare Sector Price to Earnings3Y Average 32.6x202120222023
Current Industry PE
  • Investors are pessimistic on the German Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 20.6x which is lower than its 3-year average PE of 32.6x.
  • The industry is trading close to its 3-year average PS ratio of 1.7x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 17% per year over the last three years.
  • Revenues for these companies have grown 5.5% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the German Healthcare sector?

DE Market0.26%
Healthcare0.31%
Pharma0.89%
Medical Equipment0.67%
Healthcare Services-0.97%
Life Sciences-1.10%
Biotech-2.10%
Healthtech-2.40%
Industry PE
  • Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 299x.
    • Analysts are expecting annual earnings growth of 14.3%, which is lower than the prior year's growth of 24.5% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 55% over the next 5 years.
  • In contrast, the Pharma industry is expected to see its earnings grow by 7.7% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BAYN Bayer€56.901.7%
+€923.5m
5.7%PE11.9x
SHL Siemens Healthineers€49.511.0%
+€570.9m
-12.8%PE27.2x
FME Fresenius Medical Care KGaA€35.113.6%
+€442.1m
-41.5%PE16.7x
MRK MERCK Kommanditgesellschaft auf Aktien€193.550.4%
+€369.6m
-0.2%PE24.2x
MOR MorphoSys€18.002.5%
+€15.0m
-36.3%PS2.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BAYN

€56.90

Bayer

7D

1.7%

1Y

5.7%

SYAB

€10.38

SYNLAB

7D

-1.6%

1Y

-49.4%

MOR

€18.00

MorphoSys

7D

2.5%

1Y

-36.3%

PA8

€0.71

Paion

7D

19.7%

1Y

-47.4%

GXI

€67.75

Gerresheimer

7D

-2.3%

1Y

-14.7%

FYB

€82.00

Formycon

7D

-5.3%

1Y

69.9%

EVT

€18.31

Evotec

7D

0.5%

1Y

-48.6%

T5O

€3.32

bioXXmed

7D

130.6%

1Y

-21.7%